Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 28, 2014Annals of Thoracic and Cardiovascular SurgeryOpen Access

In a retrospective analysis of 13 patients with primary pulmonary MALT lymphoma, 10 patients (76.9%) remained alive with no disease progression after treatments including surgery and/or chemotherapy during a median follow-up of 5 years.

View Full Paper
Ask AI
Bookmark
Share

Population

13 patients with primary pulmonary mucosa-associated lymphoid tissue lymphoma, median age 59 years

Design

Case_series

Follow-up

1 to 11 years

Key result

In a retrospective analysis of 13 patients with primary pulmonary MALT lymphoma, 10 patients (76.9%) remained alive with no disease progression after treatments including surgery and/or chemotherapy during a median follow-up of 5 years.

Authors

BWBo WangCZChengwei ZhangBWBin Wang

Discussion

Loading...

Member takes

Overview

Suggests favorable outcomes with surgery or chemotherapy; leaves open optimal strategy pending larger studies.

Study Design

Type

Observational (n=13)

Multicenter

No

Structured PICO

P
Population
13 patients with pathologically confirmed primary pulmonary MALT lymphoma, median age 59 years, followed for a median of 5 years to evaluate clinical features, treatment, and prognosis.
E
Exposure
Surgery, chemotherapy, or symptomatic and supportive treatment
O
Outcome
Prognosis (survival and disease progression)hard clinical

In a small series of primary pulmonary MALT lymphoma, surgical excision and/or chemotherapy resulted in good long-term survival.

Limitations

  • Small sample size due to the rarity of the disease
  • Retrospective study design

Cite This Study

Wang et al. (2014) conducted an observational in Primary pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma (n=13). Surgery and/or Chemotherapy was evaluated on Tumour-free survival and overall survival. In a retrospective analysis of 13 patients with primary pulmonary MALT lymphoma, 10 patients (76.9%) remained alive with no disease progression after treatments including surgery and/or chemotherapy during a median follow-up of 5 years.

synapsesocial.com/papers/6aade12f322a2d038800dce6https://doi.org/10.5761/atcs.oa.14-00145
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pulmonary mucosa-associated lymphoid tissue lymphoma: insights from a 15-year study at a single institution involving 14 clinical cases2024 · 5 citations
  2. 2Clinical Features and Survival Outcome of Early-Stage Primary Pulmonary MALT Lymphoma After Surgical Treatment2021 · 4 citations
  3. 3Clinical characteristics, diagnosis, treatment, and prognostic factors of pulmonary mucosa‐associated lymphoid tissue‐derived lymphoma2019 · 43 citations
  4. 4Clinical characteristics and outcomes of extranodal marginal zone lymphoma of pulmonary mucosa-associated lymphoid tissue: A single-center retrospective study2025
  5. 5Role of Surgical Therapy in Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma and Development of a Survival Nomogram2026